As of 2025-07-11, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.05 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Revive Therapeutics Ltd is -338.90%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 338.90%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.05 - -0.05 | -0.05 | -338.90% |
| DDM - Stable | (0.11) - (0.66) | (0.39) | -2034.4% |
| DDM - Multi | (0.00) - (0.01) | (0.00) | -120.9% |
| Market Cap (mil) | 8.37 |
| Beta | 3.41 |
| Outstanding shares (mil) | 418.56 |
| Enterprise Value (mil) | 8.39 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.68% |
| Cost of Debt | 5.00% |
| WACC | 7.67% |